Kevin Church
CIK 1822499 · CHIEF SCIENTIFIC OFFICER · last filed 2026-04-13
Kevin Church is a CHIEF SCIENTIFIC OFFICER who has filed 24 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for LONA, was dated Apr 13, 2026. Across all open-market trades the lifetime net is −$43.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $59.7K across reported positions. 2 Form 144 notices of planned sales are also on file; the latest, for LONA on Jul 1, 2025, lists the filer as an officer.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ATHA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
BOTHELL, WA 98011
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LONA | CHIEF SCIENTIFIC OFFICER | 25,178 | $2.37 | $59.7K | -$7.3K | 2 | 2026-04-13 |
| LeonaBio, Inc. (ATHA) Delisted | CHIEF SCIENTIFIC OFFICER | 20,681 | $6.92 | $143.1K | -$35.8K | 20 | 2026-01-05 |
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-13 | LONA | Grant (A) | — | $0 | EDGAR |
| 2026-03-05 | LONA | Mixed | +4,497 | -$7.3K | EDGAR |
| 2026-01-05 | LeonaBio, Inc. (ATHA) Delisted | Mixed | +3,791 | -$3.7K | EDGAR |
| 2025-12-29 | LeonaBio, Inc. (ATHA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-07-02 | LeonaBio, Inc. (ATHA) Delisted | Mixed | +38,140 | -$190 | EDGAR |
| 2025-07-01 | LONA | Notice (144) Officer · Planned Jul 1, 2025 No sale on file |
−8,526 | -$2.5K | EDGAR |
| 2025-03-04 | LeonaBio, Inc. (ATHA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-01-03 | LeonaBio, Inc. (ATHA) Delisted | Mixed | +38,077 | $674 | EDGAR |
| 2025-01-02 | LONA | Notice (144) Officer · Planned Jan 2, 2025 No sale on file |
−8,510 | -$4.8K | EDGAR |
| 2024-10-03 | LeonaBio, Inc. (ATHA) Delisted | Grant (A) | — | $0 | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).